BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 33106586)

  • 1. Metabolic regulation by PPARγ is required for IL-33-mediated activation of ILC2s in lung and adipose tissue.
    Fali T; Aychek T; Ferhat M; Jouzeau JY; Busslinger M; Moulin D; Eberl G
    Mucosal Immunol; 2021 May; 14(3):585-593. PubMed ID: 33106586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PPARγ enhances ILC2 function during allergic airway inflammation via transcription regulation of ST2.
    Xiao Q; He J; Lei A; Xu H; Zhang L; Zhou P; Jiang G; Zhou J
    Mucosal Immunol; 2021 Mar; 14(2):468-478. PubMed ID: 32811992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PPARɣ drives IL-33-dependent ILC2 pro-tumoral functions.
    Ercolano G; Gomez-Cadena A; Dumauthioz N; Vanoni G; Kreutzfeldt M; Wyss T; Michalik L; Loyon R; Ianaro A; Ho PC; Borg C; Kopf M; Merkler D; Krebs P; Romero P; Trabanelli S; Jandus C
    Nat Commun; 2021 May; 12(1):2538. PubMed ID: 33953160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LAIR-1 acts as an immune checkpoint on activated ILC2s and regulates the induction of airway hyperreactivity.
    Helou DG; Shafiei-Jahani P; Hurrell BP; Painter JD; Quach C; Howard E; Akbari O
    J Allergy Clin Immunol; 2022 Jan; 149(1):223-236.e6. PubMed ID: 34144112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Respiratory syncytial virus prevents the subsequent development of ovalbumin-induced allergic responses by inhibiting ILC2 via the IL-33/ST2 pathway.
    Wang D; Bai S; Cui Y; Zhao N; Qi F; Liu J; Zeng S; Xu L; Hu H; Liu B
    Immunotherapy; 2018 Sep; 10(12):1065-1076. PubMed ID: 30027786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Th2 cell-derived IL-4/IL-13 promote ILC2 accumulation in the lung by ILC2-intrinsic STAT6 signaling in mice.
    Symowski C; Voehringer D
    Eur J Immunol; 2019 Sep; 49(9):1421-1432. PubMed ID: 31144294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of type 2 innate lymphoid cell-dependent airway hyperreactivity by butyrate.
    Thio CL; Chi PY; Lai AC; Chang YJ
    J Allergy Clin Immunol; 2018 Dec; 142(6):1867-1883.e12. PubMed ID: 29522844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macrophages regulate lung ILC2 activation via Pla2g5-dependent mechanisms.
    Yamaguchi M; Samuchiwal SK; Quehenberger O; Boyce JA; Balestrieri B
    Mucosal Immunol; 2018 May; 11(3):615-626. PubMed ID: 29346348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The NF-κB Transcription Factor c-Rel Modulates Group 2 Innate Lymphoid Cell Effector Functions and Drives Allergic Airway Inflammation.
    Mindt BC; Krisna SS; Duerr CU; Mancini M; Richer L; Vidal SM; Gerondakis S; Langlais D; Fritz JH
    Front Immunol; 2021; 12():664218. PubMed ID: 34867937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adiponectin restrains ILC2 activation by AMPK-mediated feedback inhibition of IL-33 signaling.
    Wang L; Luo Y; Luo L; Wu D; Ding X; Zheng H; Wu H; Liu B; Yang X; Silva F; Wang C; Zhang X; Zheng X; Chen J; Brigman J; Mandell M; Zhou Z; Liu F; Yang XO; Liu M
    J Exp Med; 2021 Feb; 218(2):. PubMed ID: 33104171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. c-Rel Is Required for IL-33-Dependent Activation of ILC2s.
    Zaini A; Fulford TS; Grumont RJ; Runting J; Rodrigues G; Ng J; Gerondakis S; Zaph C; Scheer S
    Front Immunol; 2021; 12():667922. PubMed ID: 34194431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting androgen signaling in ILC2s protects from IL-33-driven lung inflammation, independently of KLRG1.
    Blanquart E; Mandonnet A; Mars M; Cenac C; Anesi N; Mercier P; Audouard C; Roga S; Serrano de Almeida G; Bevan CL; Girard JP; Pelletier L; Laffont S; Guéry JC
    J Allergy Clin Immunol; 2022 Jan; 149(1):237-251.e12. PubMed ID: 33964300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-33-Responsive Group 2 Innate Lymphoid Cells Are Regulated by Female Sex Hormones in the Uterus.
    Bartemes K; Chen CC; Iijima K; Drake L; Kita H
    J Immunol; 2018 Jan; 200(1):229-236. PubMed ID: 29133293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leukotriene C4 Potentiates IL-33-Induced Group 2 Innate Lymphoid Cell Activation and Lung Inflammation.
    Lund SJ; Portillo A; Cavagnero K; Baum RE; Naji LH; Badrani JH; Mehta A; Croft M; Broide DH; Doherty TA
    J Immunol; 2017 Aug; 199(3):1096-1104. PubMed ID: 28667163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allergen-Experienced Group 2 Innate Lymphoid Cells Acquire Memory-like Properties and Enhance Allergic Lung Inflammation.
    Martinez-Gonzalez I; Mathä L; Steer CA; Ghaedi M; Poon GF; Takei F
    Immunity; 2016 Jul; 45(1):198-208. PubMed ID: 27421705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary innate lymphoid cells are major producers of IL-5 and IL-13 in murine models of allergic asthma.
    Klein Wolterink RG; Kleinjan A; van Nimwegen M; Bergen I; de Bruijn M; Levani Y; Hendriks RW
    Eur J Immunol; 2012 May; 42(5):1106-16. PubMed ID: 22539286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NRP1 downregulation correlates with enhanced ILC2 responses during IL-33 challenge.
    Wang Y; Liu G; Wang J; Zhou P; Zhang L; Liu Q; Zhou J
    Immunology; 2024 Jun; 172(2):226-234. PubMed ID: 38409805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T cells and ILC2s are major effector cells in influenza-induced exacerbation of allergic airway inflammation in mice.
    Li BWS; de Bruijn MJW; Lukkes M; van Nimwegen M; Bergen IM; KleinJan A; GeurtsvanKessel CH; Andeweg A; Rimmelzwaan GF; Hendriks RW
    Eur J Immunol; 2019 Jan; 49(1):144-156. PubMed ID: 29762870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-17-producing ST2
    Cai T; Qiu J; Ji Y; Li W; Ding Z; Suo C; Chang J; Wang J; He R; Qian Y; Guo X; Zhou L; Sheng H; Shen L; Qiu J
    J Allergy Clin Immunol; 2019 Jan; 143(1):229-244.e9. PubMed ID: 29625134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein kinase Cθ controls type 2 innate lymphoid cell and T
    Madouri F; Chenuet P; Beuraud C; Fauconnier L; Marchiol T; Rouxel N; Ledru A; Gallerand M; Lombardi V; Mascarell L; Marquant Q; Apetoh L; Erard F; Le Bert M; Trovero F; Quesniaux VFJ; Ryffel B; Togbe D
    J Allergy Clin Immunol; 2017 May; 139(5):1650-1666. PubMed ID: 27746240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.